Our board members are public health and business leaders from the countries we serve and the United States. The board provides governance and fiduciary oversight, sets policy, and assesses PATH's overall performance.
- Jo Addy
- Dean Allen
- Kofi Amegashie
- Phyllis Campbell
- Alex Chika Ezeh
- George Gotsadze
- Eivor Halkjaer
- David King
- Tsitsi Masiyiwa
- Vincent McGee
- Felix Olale
- Kevin Reilly
- Raj Vattikuti
- Ireena Vittal
- Yehong Zhang
Jo Addy, MBA, MPA
Jo Addy, MBA, MPA, is a veteran corporate strategist and international economist. She is the founder and managing director of Alsweb, which designs strategic platforms for global for-profit and nonprofit clients. Ms. Addy has implemented business development initiatives worldwide, and she has developed systems and metrics to monitor political and business risk for World Bank and international bank portfolios.
Ms. Addy previously served as vice president for administration and communications for Plebys International, helping to secure $40 million in social capital for clean water technologies that reached 3 million people. She also founded UniMed Ventures Inc., a medical supply distributorship in Accra, Ghana. Ms. Addy has led numerous boards and volunteers for the American Red Cross as a regional lead for international humanitarian law dissemination and a supervising specialist for disaster logistics.
Ms. Addy earned an MBA from Adelphi University in New York and a MPA with specialization in corporate governance from the Harvard Kennedy School. A graduate of Smith College, she achieved doctoral candidacy in economics at Stanford University.
Chair and Treasurer
Dean Allen is chief executive officer of McKinstry, a design/build mechanical and electrical firm headquartered in Seattle. Mr. Allen has more than 35 years of experience in the design, construction, and real estate industries in the Pacific Northwest. Under his leadership, McKinstry has grown from a mechanical contractor into a comprehensive design, build, operate, and maintain enterprise with more than $500 million per year in revenues and more than 1,800 employees. A leader in the energy and sustainability aspects of the industry, McKinstry serves energy service clients from 21 offices located across the Midwest and Western United States.
Mr. Allen has served the community in a variety of industry and philanthropic roles. Beyond his board role at PATH, he currently sits on the boards of Seattle Children’s Hospital, where he is chair of the Research Institute Advisory Board; Global Partnerships; and Washington STEM. He also serves on the Washington Roundtable and the Partnership for Learning.
Mr. Allen earned BS degrees in molecular biology and psychology from the University of Washington, where he graduated magna cum laude.
Kofi Amegashie, MSc
Kofi Amegashie, MSc, is a chemical engineer by training, with more than 25 years of business experience with Chevron Corporation, the International Finance Corporation, and the Coca-Cola Company in a variety of functions in Asia, Africa, Europe, and North America. He is currently managing executive, Africa, at the Johannesburg-listed pharmaceutical company, Adcock Ingram Healthcare Pty. Ltd., with responsibility for all business operations in Africa, outside of South Africa.
Following his Chevron career, Mr. Amegashie wanted to contribute to the growth of business in Africa and joined the International Finance Corporation (IFC) of the World Bank Group, with responsibility for development of small-to-medium enterprises in Africa. He subsequently cofounded a pan-Africa consulting firm, Strat Afrique, located in Johannesburg and Accra and specializing in business strategy development and implementation. Mr. Amegashie also served as director for marketing, strategy, and business planning for The Coca-Cola Company in Nigeria and as president of the Advertisers Association of Nigeria.
Mr. Amegashie earned a master of science in management from the London Business School and holds a bachelor of science from the School of Engineering at Exeter University.
Phyllis Campbell, MBA
Phyllis Campbell, MBA, is the chair, Pacific Northwest, for JPMorgan Chase & Co. Based in Seattle, she is the firm’s senior executive in Washington, Oregon, and Idaho; she also serves on JPMorgan Chase’s Executive Committee. Previously, she was president and CEO of The Seattle Foundation, the largest community foundation in Washington state, with nearly $600 million in charitable assets. Prior to that, she served as president and CEO of US Bank of Washington from 1993 to 2001. Under her leadership, the bank grew through acquisitions and strong marketing initiatives.
Ms. Campbell currently serves on the boards of Seattle University, Alaska Air Group, Nordstrom, and the Initiative for Global Development. She also serves on the Diversity Advisory Board for Toyota, North America. She has received many prestigious awards for her professional achievements and community service, including the Woman Who Makes A Difference Award from the International Women’s Forum, the Lifetime Achievement Award from City Year, the Distinguished Alumnus Award from Washington State University, and the Corporate Director of the Year Award from the Northwest Chapter of the National Association of Corporate Directors.
Ms. Campbell holds an MBA from the University of Washington’s Executive MBA Program and is also a graduate of the Pacific Coast Banking School at the University of Washington and Stanford University’s Executive Management Program. She received honorary doctorates from Whitworth College and Gonzaga University.
Alex Chika Ezeh, PhD, MSc
Alex Chika Ezeh, PhD, MSc, is executive director of the African Population & Health Research Center in Nairobi, Kenya, and honorary professor of public health at the University of the Witwatersrand, South Africa. He has more than 25 years of experience working in the population and public health fields and has authored numerous scientific publications covering a broad range of fields, including population and reproductive health, urban health, health metrics, and education.
Dr. Ezeh directs the Consortium for Advanced Research Training in Africa, a multi-country initiative to strengthen the training and retention of academics at African universities in the population and public health fields. He currently serves on the boards and committees of several international public health organizations, including the International Union for the Scientific Study of Population, the Alliance for Health Policy and Systems Research, and the Institute of Medicine and National Research Council.
Dr. Ezeh holds an MSc degree from the University of Ibadan in Nigeria and a PhD from the University of Pennsylvania in the United States.
George Gotsadze, MD, PhD
George Gotsadze, MD, PhD, has more than 15 years of experience in health policy and systems. Since 1996, he has led Georgian think tank Curatio International Foundation, which focuses on health policy and health systems issues, primarily in the post-Soviet states. Dr. Gotsadze manages a portfolio of programs, which the foundation implements in various countries and regions of the world.
Dr. Gotsadze is associate professor and teaches health care financing at the School of Public Health, Tbilisi Medical University. He also serves as a vice chair of the Technical Review Panel of the Global Fund to Fight AIDS, Tuberculosis and Malaria, the Geneva-based innovative financing institution that provides funding to countries to support programs that prevent, treat, and care for people with HIV and AIDS, tuberculosis, and malaria.
Eivor Halkjaer is a former senior advisor to the director general of the Swedish International Development Cooperation Agency (Sida) in Stockholm, Sweden. From 1997 to 2006, she held several diplomatic posts, serving as Sweden’s ambassador to Nicaragua, Costa Rica, Cuba, Guatemala, El Salvador, Honduras, and Belize.
Ms. Halkjaer previously served in various roles at Sida over two decades, including as assistant director general for Latin America for many years. In the 1970s and 80s, she was a board member of the Swedish Institute for Latin American Affairs.
David King, JD
David King, JD, is the chairman and chief executive officer of Laboratory Corporation of America Holdings (LabCorp), one of the world’s largest networks of clinical laboratories. Prior to joining LabCorp in 2001, Mr. King worked for many years as the company’s outside counsel as a partner with Hogan & Hartson LLP (now HoganLovells) in Baltimore, Maryland.
Mr. King sits on the board of Cardinal Health, Inc., a Fortune 100 healthcare company. He also chairs the board of the American Clinical Laboratory Association and serves on the board of the Seattle Science Foundation.
Mr. King earned a JD degree from the University of Pennsylvania Law School and an AB degree from Princeton University.
Tsitsi Masiyiwa is the executive chairperson of the Higher Life Foundation (HLF), which she founded with her husband. She is the head of the foundation’s five trusts that address specific education, health care, and technology needs of African communities. The flagship trust, Capernaum Trust, is presently the largest privately funded scholarship program in sub-Saharan Africa and provides full scholarships to students in primary school, high school, and university.
Ms. Masiyiwa takes a practical approach to poverty eradication by spearheading the use of technology and innovation in her foundation’s programs to facilitate efficient, scalable, and sustainable impact. She is also a founding member of the African Philanthropy Forum and a member of the Advisory Council for the Global Philanthropy Forum.
Vincent McGee has worked for more than 35 years as an executive, consultant, and volunteer activist for nonprofits and foundations, particularly those supporting human rights, social change, and economic justice. He serves on the boards of The Overbrook Foundation and several additional foundations.
Previous roles include senior advisor at Atlantic Philanthropies, vice president for development at the City University of New York, board chair and CEO of FoodChange, vice president and secretary of the Irene Diamond Fund, and executive director of the Aaron Diamond Foundation. During Mr. McGee’s tenure, the foundation distributed $220 million for medical research, minority education, the arts, and human and civil rights. He also served on the board of Amnesty International, United States, for more than ten years and was its chair for two years.
Mr. McGee graduated from the University of Rochester and received an honorary doctor of law degree from the Graduate Center of the City University of New York in 2003.
Felix Olale, MD, PhD
Felix Olale, MD, PhD, is the executive chairman of the Excelsior Group, a corporate advisory and capital placement company based in New York and Nairobi. His work is focused on unlocking private-sector investments in health infrastructure, including public-private partnerships, across sub-Saharan Africa. He also serves as the chairman of the Wellness Medical Group, an Excelsior portfolio company, and as the academic director for Strathmore University’s MBA in Healthcare program.
Dr. Olale is a senior advisor to several global institutions, including the World Bank/IFC group’s Healthcare for Africa Initiative, the Bill & Melinda Gates Foundation, and the Clinton Health Access Initiative.
Dr. Olale received his medical and doctorate degrees from New York University School of Medicine. He completed his undergraduate degree at the University of Pennsylvania.
Kevin Reilly, MBA
Kevin Reilly is a senior business executive with more than 30 years’ experience in the pharmaceutical and vaccine industries. During his 20 years with Wyeth Pharmaceuticals, he served in several positions covering responsibilities in Canada, Asia, and the Pacific region. From 1999 until his retirement in 2003, he was president of Wyeth’s $2 billion Vaccine and Nutrition Division.
Prior to joining Wyeth, Mr. Reilly spent ten years with Connaught Laboratories, a major vaccine manufacturer, in positions of increasing responsibility, including three years as executive vice president from 1980 to 1983. Mr. Reilly currently serves on the board of The Sabin Vaccine Institute. He has served on the boards of a number of biotech companies and was board chair for Vaxgen Inc. He has also served on the board of the GAVI Alliance and on the management committee of the Accelerated Development and Introduction Program.
Mr. Reilly is a native of Australia. He earned his MBA from York University in Toronto, Canada, and is also a graduate of the Advanced Management Program of Harvard Business School.
Raj Vattikuti, MS
Raj Vattikuti, MS, founded Michigan-based Covansys, an information technology company listed on the NASDAQ and sold to Computer Sciences Corporation in 2007. Mr. Vattikuti recently founded Altimetrik, a company focusing on business innovation by leveraging mobile technologies. He and his wife, Padma, founded the Vattikuti Foundation in 1997 in Michigan to serve the southeast Michigan community and other parts of the world, particularly India. The foundation is focused on and committed to the charitable advancement of multidisciplinary robotic surgery, poverty alleviation, and development programs. It supported the creation of the Vattikuti Urology Institute at Henry Ford Hospitals and the Vattikuti Digital Breast Diagnostic Center at Beaumont Hospitals.
Mr. Vattikuti holds a master of science in electrical and computer engineering from Wayne State University and a bachelor of science in electrical engineering from the College of Engineering, Guindy, India. He also holds an honorary doctorate in business administration from Bryant College.
Ireena Vittal, MBA
Ireena Vittal, MBA, has significant expertise in emerging markets, Indian agriculture, and urbanization. She has contributed in a variety of private-sector roles, most recently as partner at McKinsey & Co., where she was a founding member of both the economic development and global emerging markets practices. Prior to her 16-year tenure at McKinsey, Vittal held positions at Max Touch (now Vodafone) and Nestlé.
Vittal is an independent advisor to a range of companies, including Godrej Consumer, AXIS Bank, Wipro Ltd., Tata Global Beverages, the Indian Hotels Company, and Titan Company, and she serves on the global advisory board of ideo.org.
Ms. Vittal received a bachelor of science in electronics from Osmania University and an MBA from the Indian Institute of Management, Calcutta.
Yehong Zhang, PhD
Yehong Zhang, PhD, is general manager, Greater China, for Aetna International, a leading global diversified health care solutions company. Based in Aetna’s offices in Shanghai, Dr. Zhang is responsible for the company’s growth in China, Hong Kong, Macau, and Taiwan.
Prior to joining Aetna International in 2013, Dr. Zhang was CEO of Simcere MSD Pharmaceutical Co. Ltd, a joint venture established in 2012 between Simcere, a leading China-based pharmaceutical manufacturer, and Merck & Co., one of the world’s largest multinational drug companies. Previously, he was Simcere’s president, where he was instrumental in driving strategic partnerships with several large multinational pharmaceutical companies to serve China’s rapidly expanding health care needs.
Prior to Simcere, Dr. Zhang was a practice leader for McKinsey & Co.’s health care consultancy efforts in China, where he advised local health care companies and worked closely with government stakeholders. Earlier, he was the China president for Merck and held a similar role for IMS Health, a leading health care information, services, and technology company.
A native of China, Dr. Zhang was educated in the United States. He holds a doctorate in engineering from the University of Pennsylvania, an MBA from the Wharton School, and an undergraduate degree from Harvard University.
Photos: Jo Addy, Dawdy Photography; Kofi Amegashie, courtesy of Adcock Ingram; Phyllis Campbell, PATH/Patrick McKern; Alex Chika Ezeh, courtesy of Alex Chika Ezeh; David King, courtesy of LabCorp; Felix Olale, Shaban Omboke; Raj Vattikuti, courtesy of Raj Vattikuti; Yehong Zhang, Aetna International; all others, Julia Fiset.